I now have comprehensive information from Harrison's, Tintinalli's, Washington Manual, and Fuster's Heart. Here is the full detailed answer:
NSTEMI - What It Is and How to Diagnose It
What Is NSTEMI?
NSTEMI stands for Non-ST-Elevation Myocardial Infarction - a heart attack in which part of the myocardium (heart muscle) is permanently damaged due to prolonged ischemia, but the ECG does not show the classic ST-segment elevation seen in STEMI.
It belongs to the broader category of Acute Coronary Syndromes (ACS), which are classified as:
| Condition | ECG | Troponin | Meaning |
|---|
| STEMI | ST elevation | Elevated | Full-thickness infarction, complete occlusion |
| NSTEMI | No ST elevation (ST depression / T-wave changes / normal) | Elevated | Partial-thickness infarction, partial/transient occlusion |
| Unstable Angina (UA) | No ST elevation | Normal | Ischemia without necrosis |
The key distinction between NSTEMI and UA is troponin elevation - if troponin rises above the 99th percentile, it is NSTEMI; if troponin is normal, it is UA.
Spectrum of acute coronary syndromes - from unstable angina to NSTEMI to STEMI (Harrison's Principles of Internal Medicine, 22e)
Pathophysiology (Why It Happens)
NSTEMI results from an imbalance between myocardial oxygen supply and demand, typically from coronary arterial thrombosis caused by one or more of these mechanisms:
- Plaque rupture with inflammation - thin-capped lipid-rich plaque fissures; inflammatory T-cell response drives thrombosis.
- Plaque rupture without inflammation - mechanical fissuring.
- Plaque erosion - present in at least one-third of ACS cases; the overlying endothelium erodes, exposing the subendothelium and triggering thrombus.
- Spasm or microvascular dysfunction - no thrombosis; epicardial or microvascular spasm, typically on a background of fixed obstruction.
The thrombus is non-occlusive (partial blockage) - this is why ST elevation does not appear (subendocardial ischemia pattern) but necrosis still occurs.
On coronary angiography, patients with NSTEMI show:
- Left main stenosis: <10%
- Three-vessel CAD: ~35%
- Two-vessel CAD: ~25%
- Single-vessel CAD: ~20%
- No apparent critical stenosis: ~10% (microvascular or spasm)
Clinical Presentation
Symptoms
Chest discomfort in NSTEMI typically has at least one of three features:
- Occurs at rest or with minimal exertion, lasting more than 10 minutes
- Recent onset (within the prior 2 weeks)
- Crescendo pattern - distinctly more severe, prolonged, or frequent than previous episodes
Character of chest pain:
- Usually substernal, severe, pressure-like or squeezing
- Radiates to the left arm, left shoulder, neck, or jaw
- Associated with diaphoresis, nausea, shortness of breath
Anginal equivalents (especially in women, elderly, and diabetics):
- Dyspnea alone
- Epigastric discomfort / nausea
- Unexplained fatigue or weakness
- Pain only in the jaw, shoulder, or arm
Physical examination may be entirely normal, but in large NSTEMI:
- Diaphoresis, pale/cool skin
- Sinus tachycardia
- S3 or S4 heart sounds
- Basilar lung crackles (rales)
- Hypotension, or in extreme cases, cardiogenic shock
Always exclude life-threatening mimics: pulmonary embolism, aortic dissection, cardiac tamponade.
Diagnosis of NSTEMI
Diagnosis is based on a triad: symptoms + ECG + cardiac biomarkers.
1. History and Risk Factor Assessment
Increase clinical suspicion with:
- Age ≥65 years
- Known CAD (stenosis ≥50%)
- Diabetes mellitus
- Hypertension, hyperlipidemia, smoking
- Family history of premature CAD (first-degree relative before age 50)
- Prior MI, PCI, or CABG
2. ECG (12-Lead)
Perform within 10 minutes of presentation and interpret immediately (2025 ACC/AHA guideline, Class I).
NSTEMI ECG findings (~50% of patients have significant changes):
| Finding | Description | Significance |
|---|
| ST-segment depression | ≥0.5 mm in V2-V3; ≥1 mm in all other leads; in ≥2 contiguous leads | Most specific for ischemia, especially if dynamic and symptomatic |
| T-wave inversions | New deep inversions ≥0.3 mV | Significant; less specific unless new and deep |
| Normal ECG | No ischemic changes | Does NOT rule out NSTEMI - diagnosis still requires troponin |
| Transient ST elevation | Brief, resolving <20 min | Can occur during ischemic episodes |
Important special patterns:
-
Wellens' Syndrome - deep symmetric T-wave inversions or biphasic T waves in V2-V3 (sometimes V1-V6), seen when pain-free, with normal/minimally elevated biomarkers. Indicates a critical proximal LAD stenosis - very high risk for imminent large MI. About 15% of unstable angina patients display this sign.
-
ST depression in multiple leads + ST elevation in aVR and/or V1 - suggests ischemia from left main or multivessel disease - very high risk.
-
Posterior STEMI pattern (ST depression in V1-V3 = mirror image) - always obtain posterior leads (V7-V9) if suspected.
Serial ECGs should be obtained if the initial ECG is non-diagnostic. Compare with prior ECGs to identify new changes.
The posterior circulation (circumflex artery) is poorly seen on standard ECG - always consider posterior leads or urgent echocardiography when posterior NSTEMI is suspected.
3. Cardiac Biomarkers (Troponin) - The Definitive Diagnostic Test
Troponin I (cTnI) or Troponin T (cTnT) is the standard and preferred biomarker.
The diagnostic rule:
NSTEMI = troponin value above the 99th percentile of the upper reference limit, with a rising and/or falling pattern (delta troponin), in the appropriate clinical context.
Testing Protocol (ACC/AHA 2025 / ESC Guidelines):
| Protocol | Draw Times |
|---|
| Standard | At presentation, then at 3-6 hours |
| High-sensitivity troponin (hsTn) rapid algorithm | 0 h and 1 hour (ESC 0h/1h protocol) |
| If initial and 3-6h draws are normal but suspicion remains | Draw again at 6+ hours after symptom onset |
High-sensitivity cardiac troponin (hs-cTn):
- Detects 90-100% of AMI at arrival
- Identifies small rises and falls (delta change) that older assays missed
- The 1-hour rapid rule-out algorithm (no abnormal elevation at 0 h or 1 h) has been endorsed by recent guidelines
- Has led to an increase in NSTEMI diagnoses (and corresponding decrease in UA) because smaller levels of necrosis are now detectable
Key biomarker facts:
- Troponin peaks at 12-24 hours after symptom onset and gradually decreases
- Elevations persist for up to 14 days (or longer)
- CK-MB is no longer recommended as a primary diagnostic marker for NSTEMI - it lacks cardiac specificity (also present in skeletal muscle)
- BNP/NT-proBNP elevation in ACS without known heart failure suggests large infarction - warrants urgent angiography
- Troponin elevation of any amount is always associated with worse outcomes - more elevation = worse prognosis
Elevated troponin with a 3-fold higher risk of death (1.6% vs. 5.3%) compared to non-elevated patients.
Causes of Troponin Elevation That Are NOT NSTEMI (must distinguish):
| Category | Examples |
|---|
| Reduced supply (non-ACS ischemia) | Coronary spasm, hypotension, severe anemia, tachyarrhythmia |
| Cardiac non-ischemic | Myocarditis, heart failure, cardiomyopathy, cardiac contusion, ablation |
| Systemic illness | Pulmonary embolism, sepsis, renal failure, stroke, rhabdomyolysis |
| Endocrine | Hypothyroidism, pheochromocytoma |
For NSTEMI, troponin must show an acute dynamic pattern (rise and/or fall) consistent with ischemic symptoms and ECG changes.
4. Additional Investigations
| Test | Purpose |
|---|
| Complete blood count | Anemia contributing to ischemia; thrombocytopenia altering antiplatelet management |
| Basic metabolic panel / electrolytes | Hyperkalemia can mimic ischemic ECG changes; renal function affects drug dosing |
| Fasting glucose + lipid panel | Cardiovascular risk factors |
| Chest X-ray | Assess for pulmonary edema, cardiac size, aortic widening (dissection) |
| Echocardiography | Wall motion abnormalities in the ischemic territory; LV function; excludes other diagnoses |
| Coronary angiography | Definitive for anatomy; combined with PCI for revascularization |
5. Risk Stratification Scores
Once NSTEMI is confirmed, quantify risk using validated scores:
TIMI Score (7 variables, each = 1 point):
- Age ≥65 years
- Known CAD (stenosis ≥50%)
- ST deviation >0.5 mm on ECG
- ≥2 anginal events in prior 24 hours
- Elevated cardiac markers
- Prior aspirin use (paradoxically indicates higher-risk patients)
- ≥3 CAD risk factors
| TIMI Score | 14-day risk of death/MI/urgent revascularization |
|---|
| 0-1 | 5% |
| 2 | 8% |
| 3 | 13% |
| 4 | 20% |
| 5 | 26% |
| 6-7 | 41% |
GRACE Score - uses 8 variables (age, heart rate, BP, creatinine, Killip class, cardiac arrest, ST deviation, troponin) - most validated for predicting in-hospital and 6-month mortality.
HEART Score - History, ECG, Age, Risk factors, Troponin - commonly used in emergency departments to guide early discharge vs. admission decisions.
6. Summary: Diagnostic Criteria for NSTEMI
A diagnosis of NSTEMI requires ALL of the following:
- Clinical symptoms consistent with ACS (chest pain/discomfort at rest, or crescendo pattern)
- No persistent ST-segment elevation on ECG (the absence of STEMI)
- Troponin above the 99th percentile of the upper reference limit with a dynamic rise and/or fall pattern
- No alternative explanation for the troponin elevation (e.g., not purely due to PE, sepsis, renal failure alone)
Sources: Harrison's Principles of Internal Medicine, 22e (2025); Tintinalli's Emergency Medicine, 8e; The Washington Manual of Medical Therapeutics; Fuster and Hurst's The Heart, 15th ed.; 2025 ACC/AHA ACS Guidelines; AHA/ACC 2014 NSTE-ACS Guideline